These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7409887)

  • 21. Effects of gestational age, birth weight, and hypoxemia on pharmacokinetics of amikacin in serum of infants.
    Myers MG; Roberts RJ; Mirhij NJ
    Antimicrob Agents Chemother; 1977 Jun; 11(6):1027-32. PubMed ID: 879747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological evaluation of amikacin in neonates.
    Howard JB; McCracken GH
    Antimicrob Agents Chemother; 1975 Jul; 8(1):86-90. PubMed ID: 1164009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aminoglycoside dosing in renal transplant patients. Comparison of nomogram and individualized pharmacokinetic methods in patients with shifting renal function.
    Tofte RW; Canafax DM; Simmons RL; Peterson PK
    Ann Surg; 1982 Mar; 195(3):287-93. PubMed ID: 7036923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective Evaluation of a Model-Based Dosing Regimen for Amikacin in Preterm and Term Neonates in Clinical Practice.
    Smits A; De Cock RF; Allegaert K; Vanhaesebrouck S; Danhof M; Knibbe CA
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6344-51. PubMed ID: 26248375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum concentrations and inhibitory ratios during amikacin therapy of gram-negative infections.
    Farchione LA; Chudzik GM
    J Clin Pharmacol; 1978; 18(8-9):432-8. PubMed ID: 690253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is ceftizoxime an appropriate surrogate for amikacin in neonatal sepsis treatment? A randomized clinical trial.
    Taheri PA; Eslamieh H; Salamati P
    Acta Med Iran; 2011; 49(8):499-503. PubMed ID: 22009803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of chronologic age on the serum concentrations of amikacin in sick term and premature infants.
    Prober CG; Yeager AS; Arvin AM
    J Pediatr; 1981 Apr; 98(4):636-40. PubMed ID: 7205495
    [No Abstract]   [Full Text] [Related]  

  • 28. Aminoglycosides and ampicillin to newborn infants. Kinetics and dosage calculations.
    Colding H
    Dan Med Bull; 1985 Oct; 32(5):243-50. PubMed ID: 3931987
    [No Abstract]   [Full Text] [Related]  

  • 29. An overview of pediatric experience with amikacin.
    Yow MD
    Am J Med; 1977 Jun; 62(6):954-8. PubMed ID: 868913
    [No Abstract]   [Full Text] [Related]  

  • 30. The necessity of increased doses of amikacin in burn patients.
    Zaske DE; Sawchuk RJ; Strate RG
    Surgery; 1978 Nov; 84(5):603-8. PubMed ID: 715674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amikacin therapy of gram-negative bacteremia.
    Tally FP; Gorbach SL
    Am J Med; 1977 Jun; 62(6):936-9. PubMed ID: 868909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dibekacin in the newborn: pharmacokinetics and evaluation of ototoxicity in neonates and premature infants.
    Bégué P; Safran C; Quiniou F; Michel B; Laget P
    Dev Pharmacol Ther; 1984; 7 Suppl 1():116-20. PubMed ID: 6518950
    [No Abstract]   [Full Text] [Related]  

  • 33. Guidelines for adequate chemotherapeutic dosage in newborns and infants with septicaemia and meningitis.
    Marget W; Belohradsky BH; Roos R
    Infection; 1980; Suppl 1():82-6. PubMed ID: 7399719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amikacin therapy for gram-negative septicemia.
    Meyer RD; Lewis RP; Finegold SM
    Am J Med; 1977 Jun; 62(6):930-5. PubMed ID: 868908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of three antibiotic programs in newborn infants.
    Marks S; Marks MI; Dupont C; Hammerberg S
    Can Med Assoc J; 1978 Mar; 118(6):659-62. PubMed ID: 657058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A controlled study of the nephrotoxicity of mezlocillin and amikacin in the neonate.
    Adelman RD; Wirth F; Rubio T
    Am J Dis Child; 1987 Nov; 141(11):1175-8. PubMed ID: 3314475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and renal toxicity of one daily dose of amikacin versus conventional dosage regime.
    Guadalupe Vásquez-Mendoza M; Vargas-Origel A; Del Carmen Ramos-Jiménez A; Aguilar-Orozco G; Romero-Gutiérrez G
    Am J Perinatol; 2007 Feb; 24(2):141-6. PubMed ID: 17304422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of a relationship between the serum concentration of aminoglycosides and ototoxicity in neonates.
    Setiabudy R; Suwento R; Rundjan L; Yasin FH; Louisa M; Dwijayanti A; Simanjuntak E
    Int J Clin Pharmacol Ther; 2013 May; 51(5):401-6. PubMed ID: 23557866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nephrotoxicity induced by gentamicin and amikacin.
    Smith CR; Maxwell RR; Edwards CQ; Rogers JF; Lietman PS
    Johns Hopkins Med J; 1978 Mar; 142(3):85-90. PubMed ID: 342789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of results of clinical trials with amikacin.
    Gooding PG; Berman E; Lane AZ; Agre K
    J Infect Dis; 1976 Nov; 134 SUPPL():S441-5. PubMed ID: 792360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.